You have 9 free searches left this month | for more free features.

BCVA

Showing 1 - 25 of 1,561

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Visual Impairment, Myopia, Hyperopia Trial in Newark (With Try-on glasses)

Completed
  • Visual Impairment
  • +3 more
  • With Try-on glasses
  • Newark, California
    EyeQue
Jan 20, 2023

Refractive Errors, Vision Disorders Trial in Newark (EQ103)

Recruiting
  • Refractive Errors
  • Vision Disorders
  • EQ103
  • Newark, California
    EyeQue
Jan 5, 2022

Imaging of the Angiofibrotic Switch in Neovascular AMD

Unknown status
  • Age-related Macular Degeneration
  • Choroidal Neovascularization
  • Best-corrected Visual acuity testing (BCVA)
  • +7 more
  • Vienna, Austria
    Medical University of Vienna
Feb 19, 2020

Ranibizumab 0.5 mg for Diabetic Macular Edema With Initial

Completed
  • Diabetic Macular Edema
    • Seoul, Korea, Republic of
      Novartis Investigative Site
    Apr 4, 2023

    rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

    Completed
    • Age Related Macular Degeneration
    • Bern, Switzerland
    • +1 more
    Nov 28, 2022

    Neovascular Age-related Macular Degeneration Trial in Worldwide (SOK583A1 (40 mg/mL), Eylea EU (40 mg/mL))

    Active, not recruiting
    • Neovascular Age-related Macular Degeneration
    • SOK583A1 (40 mg/mL)
    • Eylea EU (40 mg/mL)
    • Phoenix, Arizona
    • +101 more
    Jan 23, 2023

    Neovascular Age-related Macular Degeneration Trial in United States (SUSVIMO (ranibizumab injection), LUCENTIS (ranibizumab

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • SUSVIMO (ranibizumab injection)
    • LUCENTIS (ranibizumab injection)
    • Mesa, Arizona
    • +32 more
    Jan 13, 2023

    Two Solutions of Intracameral Anesthesia During Cataract Surgery

    Completed
    • Cataract
    • +2 more
    • Lublin, Poland
      General Department of Ophthalmology in Lublin
    Nov 14, 2019

    Recurrent Postoperative Macular Edema Treated With OZURDEX

    Completed
    • Macular Edema
      • Beijing, Beijing, China
        Peking University Third Hosipital
      May 10, 2022

      Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML

      Withdrawn
      • Wet Macular Degeneration
      • Aflibercept 40 MG/ML [Eylea]
      • +2 more
      • Prague, Czechia
        Department of Ophthalmology, Faculty hospital Kralovske Vinohrad
      Aug 7, 2022

      Polypoidal Choroidal Vasculopathy Trial in Peking (non-interventional)

      Recruiting
      • Polypoidal Choroidal Vasculopathy
      • non-interventional
      • Peking, Beijing, China
        Peking Union Medical College Hospital
      Nov 28, 2022

      Retinitis Pigmentosa, Stem Cell Transplant Trial in Istanbul (Stem cell implantation)

      Completed
      • Retinitis Pigmentosa
      • Stem Cell Transplant
      • Stem cell implantation
      • Istanbul, Turkey
        Acıbadem University
      Jan 25, 2023

      Diabetic Macular Edema Trial in Worldwide (MYL-1701P, Eylea)

      Completed
      • Diabetic Macular Edema
      • Phoenix, Arizona
      • +72 more
      Mar 15, 2022

      Myopia Trial in Shenyang (0.01% atropine, 0.9% sodium chloride)

      Not yet recruiting
      • Myopia
      • 0.01% atropine
      • 0.9% sodium chloride
      • Shenyang, Liaoning, China
        He Eye Hospital
      Sep 10, 2023

      Learn More About How Well Aflibercept 8 mg Works in Treating

      Not yet recruiting
      • Visual Impairment
      • +2 more
      • Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)
      • Multiple Locations, Australia
      • +5 more
      Oct 4, 2023

      Proliferative Diabetic Retinopathy Trial in Beijing (preoperative group and intraoperative group)

      Completed
      • Proliferative Diabetic Retinopathy
      • preoperative group and intraoperative group
      • Beijing, Beijing, China
        People's Hospital of Peking University
      Jun 1, 2022

      Myopia Trial (Atropine Sulfate)

      Not yet recruiting
      • Myopia
      • Atropine Sulfate
      • (no location specified)
      Jul 20, 2022

      Cornea Ulcer Trial in Cairo (Autologous platelet-rich plasma (PRP) eye drops)

      Completed
      • Cornea Ulcer
      • Autologous platelet-rich plasma (PRP) eye drops
      • Cairo, Egypt
        Al-Azhar University
      Aug 23, 2022

      Neovascular (Wet) Age-related Macular Degeneration Trial (Aflibercept(BAY86-5321, Eylea))

      Not yet recruiting
      • Neovascular (Wet) Age-related Macular Degeneration
      • Aflibercept(BAY86-5321, Eylea)
      • (no location specified)
      Jul 22, 2022

      Early Real-world Evidence of Brolucizumab in Neovascular

      Completed
      • Neurovascular Age-related Macular Degeneration
        • Bangalore, India
        • +3 more
        Apr 26, 2023

        Macular Degeneration Trial in Beijing (Autologous iPSC-derived RPE)

        Recruiting
        • Macular Degeneration
        • Autologous iPSC-derived RPE
        • Beijing, Beijing, China
          Beijing Tongren Hospitol,Capital Medical University
        Jun 30, 2022

        Diabetic Macular Edema Trial (RC-28E, Aflibercept)

        Not yet recruiting
        • Diabetic Macular Edema
        • RC-28E
        • Aflibercept
        • (no location specified)
        May 30, 2023

        Diabetic Macular Edema Trial (Bevacizumab Injection [Avastin] (IVB-I), Triamcinolone Acetonide 10mg/mL (IVT-II), Bevacizumab

        Completed
        • Diabetic Macular Edema
        • Bevacizumab Injection [Avastin] (IVB-I)
        • +2 more
        • (no location specified)
        May 24, 2022

        Myopia Trial in Damietta (Implantable Collamer Lens (ICL), Implantable Intraocular Lens (IPCL))

        Completed
        • Myopia
        • Implantable Collamer Lens (ICL)
        • Implantable Intraocular Lens (IPCL)
        • Damietta, Egypt
          Akram Fekry Elgazzar
        Sep 22, 2023

        Diabetic Macular Edema Trial in Giza (Lucentis alone group, Lucentis dexamethasone group)

        Completed
        • Diabetic Macular Edema
        • Lucentis alone group
        • Lucentis dexamethasone group
        • Giza, Cairo, Egypt
          Khaled G Abueleinen
        Feb 27, 2022